Allergy Therapeutics plc announced that Mary Tavener will join the Board of company as a Non-Executive Director with immediate effect. Mary will also join the Audit Committee of the Board and will work closely with the current chair Stephen Smith in anticipation of her succeeding Stephen as chair of the committee after the Group publishes its final results for the year ended 30 June 2019 in September. Mary has extensive experience in the healthcare sector, having spent more than 19 years as Chief Financial Officer and Board member of AIM listed Advanced Medical Solutions (AMS). Prior to joining AMS, Mary was the Group Financial Controller of BTP plc.